Specific question about efinopegdutide mash data anyone have experience? that I have not seen answered clearly anywhere:

Does timing matter?

Context: I am week 4 on 0.5mg sema. My provider said one thing but I have read conflicting info online.

Would appreciate hearing from people with direct experience, not just theoretical answers.

PharmacoVig_BOS's experience with Efinopegdutide MASH data resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 54 lbs in 9 months.

One thing I would add that PharmacoVig_BOS did not mention: the mental health improvements were just as significant.

Thanks for sharing this, PharmacoVig_BOS. A few questions about your Efinopegdutide MASH experience:

1. What dose did you start at?
2. How long before you noticed side effects improving?
3. Did your provider have any specific recommendations about Efinopegdutide?

I am in a similar boat and trying to learn from others' experiences before my next appointment.

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Efinopegdutide MASH data .

To answer kate.chem: I get my labs done through Quest every 3 months.

Quick update: my latest labs came back even better. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

Relevant to Efinopegdutide MASH data — here is my latest bloodwork comparison:

Key improvements: A1C 8.0% → 5.3%, triglycerides 247 → 117 mg/dL, hsCRP 6.0 → 1.1 mg/L. All on tirzepatide for 15 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.